Relapsed or refractory solid tumors or non-Hodgkin lymphoma research hub

A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma.

This study is looking into a new medication called KB-0742 for people with certain types of cancer that have come back or haven't responded to other treatments. It's an early-stage study to see if the medication is safe and what dose works best.